Sinovac says its vaccine has been approved for use in children aged 3 and above
8-06-2021, 13:21

Font size: [ A+ ] / [ A- ]

 

China has approved the emergency use of a Covid-19 vaccine for those as young as three, according to a spokesperson for Sinovac who spoke to AFP. That would make it the first country to offer jabs to young children.

 


“In recent days, the Sinovac vaccine was approved for emergency use in three- to 17-year-olds,” the spokesperson said.

 


But they did not confirm when the young children would be able to start receiving the shots, saying the schedule for the rollout will be decided by the National Health Commission “according to China’s current epidemic prevention and control needs and vaccine supply”.

 


The company has completed early phase trials of the vaccine in children and adolescents, with results to be published shortly in the Lancet scientific journal, the spokesperson added.

 


State broadcaster CCTV reported over the weekend that an unnamed official in the State Council’s epidemic response task force had said vaccines had been approved for children, and “the safety and effectiveness” had been proven.

 


A spokesperson for China’s other major vaccine, Sinopharm, said that experts had demonstrated the effectiveness of its vaccine in children, but didn’t confirm whether it had been approved for use.

 

Comments: 0
Add Comments

Name:*
E-Mail:
  Geo Keyboard  
 

Dear reader, guardian.ge welcomes your comments. Please express your views on topic and be respectful of others.

bold italic underline strike | align left centered align right | Ensert smilies insert linkInsert protected URL Choice the color | hidden text insert quote Convert selected text from transliteration to Cyrillic alphabet Insert spoiler

Code: *